Join the 200th Anniversary Celebration

Original Article

Endometrial Resection for the Treatment of Menorrhagia

Hugh O'Connor, M.R.C.O.G., and Adam Magos, M.D.

N Engl J Med 1996; 335:151-156July 18, 1996

Abstract

Background

Endometrial resection is an alternative to hysterectomy in the treatment of women with menorrhagia, but it may not control the condition. We sought to evaluate the effectiveness of such resection.

Methods

We followed 525 consecutive women (mean age at initial surgery, 42 years) for up to five years after endometrial resection. The women were examined 6 to 12 weeks after the operation and were then sent yearly questionnaires seeking information about their condition. The mean duration of follow-up was 31 months. Thirty-seven women (86 percent of the 43 women available for five years of follow-up) were followed for the entire period.

Results

Endometrial resection was completed successfully in 95 percent of the women, with operative complications in 6 percent. Forty-eight women underwent subsequent resection. The yearly questionnaires indicated that 85 to 100 percent of the women (depending on the year of follow-up) had adequately controlled menorrhagia, 26 to 40 percent had amenorrhea, 71 to 80 percent reported either a lessening of menstrual pain or no pain, and 79 to 87 percent were satisfied with the results of their surgery. No further surgery was needed by 80 percent of the women, and only 9 percent underwent hysterectomy during the five years of follow-up, with 98 percent of those operations being performed in the first three postoperative years.

Conclusions

Endometrial resection is an effective alternative to hysterectomy in women with menorrhagia.

Media in This Article

Figure 1Changes in Menstrual Blood Flow and Menstrual Pain in Women Followed for up to Five Years after a First Endometrial Resection.
Figure 2Life-Table Analysis of the Need for Further Surgery after First and Subsequent Endometrial Resections in the 525 Women in the Study.
Article

Hysteroscopic ablation of the endometrium has become an accepted alternative to hysterectomy in the treatment of menorrhagia.1 More than 10,200 of these procedures were performed in England and Wales from April 1993 through October 1994,2 for instance, only four years after the use of the technique was first reported in the United Kingdom.3 The rapid acceptance of endometrial ablation, whether performed by laser photovaporization,4,5 coagulation with a rollerball electrode,6,7 or electroresection,8,9 follows the numerous reports that the operation reduces menstrual blood loss.10 In addition, endometrial ablation is less traumatic than hysterectomy, causes less postoperative morbidity, is associated with a shorter recovery period, and can potentially be performed as day surgery.2,5,9,11-15

Unlike hysterectomy, however, endometrial ablation is not always effective. Most women who have undergone the procedure menstruate, and some have recurrent menorrhagia. In one series of 234 women undergoing endometrial resection, 10 percent required further gynecologic surgery during a 30-month follow-up period.9 The follow-up in most reports is short, often averaging less than one year, and the important issue of whether endometrial ablation would be less attractive if the probability of further intervention was found to increase with time has not been carefully studied. We report the results of a study in which a large number of women with menorrhagia who underwent transcervical resection of the endometrium were followed for up to five years, with particular attention to the need for further surgery.

Methods

Study Patients

We offered endometrial resection to women with symptomatic menorrhagia sufficiently severe to warrant hysterectomy who had not had a response to progestogens, nonsteroidal antiinflammatory drugs, antifibrinolytic drugs, danazol, or a combination of contraceptives or who had not complied with such therapy. The women were required to be 30 to 50 years old (except in unusual circumstances), to desire no further children, and to have had normal cervical smears and endometrial biopsies in the past 12 months. Some were also at high risk for operative or postoperative complications of hysterectomy.16 Women with adnexal tenderness suggestive of pelvic inflammatory disease or endometriosis, major uterovaginal prolapse, or submucosal fibroid tumors larger than 5 cm in diameter were not offered the operation. The women were told that they might need laparotomy or hysterectomy at the time of the operation and that surgery would considerably reduce their fertility and make pregnancy hazardous. Barrier methods of contraception were recommended to women who had not been sterilized.

We studied the outcome of endometrial resection in 525 consecutive women who underwent a total of 575 procedures from August 1988 through July 1993, including 46 women who had second resections and 2 who had three resections. Initially, 449 of the women had chosen endometrial resection in preference to hysterectomy, 62 were randomly assigned to undergo the procedure as part of a trial comparing it with hysterectomy, and 14 were advised to have endometrial resection for medical reasons — because, for example, they had severe rubella syndrome or cardiac valvular disease or had received a liver transplant.

Surgery

Among the 575 procedures, 394 (69 percent) were carried out after treatment with danazol or an analogue of gonadotropin-releasing hormone to thin the endometrium and facilitate surgery.17 The women were usually admitted to the hospital on the day of surgery. All received a combination of amoxicillin and clavulanate (Augmentin, SmithKline Beecham, Worthing, United Kingdom; 1.2 g intravenously) as antibiotic prophylaxis. Local anesthesia was used in 174 procedures (30 percent)12 and general anesthesia in the remaining 401 (70 percent). Focal lesions, such as submucosal fibroid tumors, were resected as described by Neuwirth,18 and then the endometrium was systematically excised3 with a 26-gauge continuous-flow resectoscope fitted with a passive handle mechanism and a 4-mm, 30-degree fore-oblique optic, an electrosurgical generator (Valleylab Force 2 or 40, Boulder, Colo.) set to produce 100 to 120 W of blended cutting–coagulation power, a 24-gauge cutting loop (or 2-mm rollerball, for electrocoagulation of the fundus and tubal ostia), and a sterile solution containing 1.5 percent glycine to distend and irrigate the uterus. All the endoscopic equipment was obtained from Karl Storz (Tuttlingen, Germany). The absorption of fluid was monitored carefully.19 Video monitoring was used during all procedures. The resected tissue was sent for histopathological study.

Follow-up

Most of the women were discharged the day after the operation and examined as outpatients 6 to 12 weeks after surgery. They then were mailed a yearly questionnaire asking about changes in their patterns of menstruation and about their overall level of satisfaction with the operation. They were also asked about current gynecologic problems, medications, and any recent surgery. If a woman did not respond within six weeks, we telephoned her or her general practitioner. Women who were not satisfied with the results of the endometrial resection were offered further treatment, usually either a second endometrial resection or a hysterectomy.

Statistical Analysis

The data were analyzed with the C-Stat (Cherwell Scientific, Oxford, United Kingdom) and Confidence Interval Analysis (BMJ, London) statistical packages. Life-table analysis with log-rank testing was used to determine the risk of treatment failure after surgery, the end point being the time when further surgery was performed.20 All the statistical tests were two-tailed.

Results

The average age of the women at entry into the study was 42 years; 12 were less than 30 years old, 5 had major medical problems, and 7 had been sterilized. Menstrual symptoms had been present for a mean of six years, and 441 of the women (84 percent) had received some medical therapy (Table 1Table 1Characteristics of the 525 Women in the Study before They Underwent Endometrial Resection.). Menorrhagia was the most common symptom, but 229 women (44 percent) also reported dysmenorrhea.

First Operation

The endometrial-resection procedure was terminated prematurely in 25 women (5 percent) for various reasons: large fibroid tumors in 10 women, fluid overload in 6, uterine perforation in 4, uterine abnormalities in 2, a poor view of the uterine cavity in 2, and a thin cesarean-section scar in 1 (Table 2Table 2Operative Findings and Results of 575 Endometrial Resections in 525 Women with Menorrhagia.). It was necessary to switch from local to general anesthesia during the operation in three women. Forty women underwent laparoscopic sterilization at the time of endometrial resection.

Ten women (2 percent) had uterine perforation during the initial endometrial resection, six of them because of the operator's inexperience. Nine perforations were recognized immediately and treated with laparotomy or laparoscopy in which the uterine defect was sutured.21 One perforation was missed at first; at laparotomy the next day, a rectal tear was found and sutured. Nineteen women each absorbed more than 2 liters of irrigating solution during the operation, without serious sequelae. Three women (0.6 percent) required the insertion of an intrauterine balloon because of bleeding after surgery, but none needed transfusions. Two women had cervical trauma during cervical dilatation at the start of surgery. There were more complications when the first endometrial resection was combined with hysteroscopic myomectomy than when resection was performed alone (15 percent vs. 5 percent, P<0.001). Preoperative thinning of the endometrium with danazol or an analogue of gonadotropin-releasing hormone had a minimal effect on the incidence of complications, but the women so treated had smaller mean deficits of fluid than the untreated women (536 vs. 729 ml), shorter operating times (33 vs. 36 minutes), and less estimated loss of blood (86 vs. 103 ml) (P<0.001 for all comparisons). No woman required emergency hysterectomy. The postoperative complications included endometritis in nine women, urinary tract infection in three, and secondary hemorrhage in two.

Normal histologic features were reported in 42 percent of endometrial specimens obtained during the initial resections, and a further 51 percent contained atrophic endometrium. The abnormal findings included polyps (in 4 percent of specimens), endometritis (in 1 percent), and cystic hyperplasia without atypia (in 0.8 percent). Despite earlier biopsy, two women were found to have atypical endometrial hyperplasia (0.4 percent); there was no evidence of hyperplasia at subsequent hysterectomy. Adenomyosis was detected in 48 specimens (9 percent).

Further Treatment

Seventeen women (3 percent) required medical therapy for recurrent menstrual symptoms and were treated with a progestogen or a nonsteroidal antiinflammatory drug. Eighty-four women (16 percent) underwent further surgery after the initial endometrial resection. Second endometrial resections were carried out because of persistent or recurrent menorrhagia in 20 women, cyclic pelvic pain in 13, pelvic pain and abnormal bleeding in 11, and a desire for amenorrhea in 4. Concurrent laparoscopic procedures included the ablation of endometriotic tissue, ovarian cystectomy, and the division of the uterosacral ligaments (in two women each) and oophorectomy and salpingectomy (one woman each).

There were 4 uterine perforations (8 percent) during the 50 subsequent endometrial resections, significantly more than occurred during the first resections (P = 0.01); all four of these women were treated with observation or laparoscopy. One woman absorbed more than 2 liters of irrigating solution. No woman in this group required emergency hysterectomy. There were two cases of postoperative endometritis.

Forty-one percent of the women had normal histologic features at the time of their second endometrial resections. Among the abnormal findings were endometrial atrophy (in 48 percent), the lack of endometrium (7 percent), adenomyosis (7 percent), reaction to a foreign body (5 percent), and endometritis (2 percent).

The most common reasons for hysterectomy in the 46 women who ultimately underwent that procedure were heavy and painful menstrual periods (18 women) and pelvic pain (14 women). Eight women underwent hysterectomy for incidental reasons, such as enlarging fibroid tumors, abnormal endometrial histology, uterovaginal prolapse, and an ovarian cyst. The other surgical procedures performed in this group were dilatation and curettage, drainage of hematometra, and laparoscopic ablation of a uterine nerve (two women each).

The results of histologic testing were available for 42 of the 46 hysterectomy specimens (91 percent). Twenty-nine specimens (69 percent) contained endometrium, and 10 (24 percent) did not; there was no comment by the pathologist about the remaining 3. The myometrium was described as normal in 18 specimens (43 percent). Ten specimens (24 percent) contained fibroid tumors, six (14 percent) had adenomyosis, and three (7 percent) had giant-cell reactions to a foreign body. There was endometriosis in four specimens and hematometra in one.

Effect on Menstruation

The proportion of women in the study for whom follow-up data were available varied with each year of the five-year follow-up period, ranging from 100 percent for the first year to 86 percent for the fifth year (Table 3Table 3Follow-up Data after Endometrial Resection in 525 Women.). The majority of women reported improvement in their menstrual periods after endometrial resection, including those who had amenorrhea at some time during follow-up (a proportion ranging from 26 percent to 40 percent) (Figure 1Figure 1Changes in Menstrual Blood Flow and Menstrual Pain in Women Followed for up to Five Years after a First Endometrial Resection.). From 71 to 80 percent of women (depending on the year of follow-up) reported that they had no menstrual pain or that their pain had lessened. Seventy-nine to 87 percent of women expressed satisfaction with the results of the first resection during each of the five years of follow-up. Among the 25 women in whom the operation could not be completed, 14 were satisfied with their surgery and only 2 later underwent hysterectomy.

Life-Table Analysis

Five years after the first endometrial resection, 80 percent of women (95 percent confidence interval, 76 to 84 percent) had had no further surgery, and 91 percent (95 percent confidence interval, 88 to 94 percent) had not had a hysterectomy (Figure 2Figure 2Life-Table Analysis of the Need for Further Surgery after First and Subsequent Endometrial Resections in the 525 Women in the Study. and Table 3). The first endometrial resections were significantly more successful than the subsequent resections in averting either hysterectomy (relative risk, 1.2; 95 percent confidence interval, 1.0 to 1.4; P<0.001) or surgery of any type (relative risk, 1.2; 95 percent confidence interval, 0.9 to 1.4; P = 0.03). Women with dysfunctional uterine bleeding were significantly less likely to require further surgery than those with submucous fibroid tumors (relative risk, 1.1; 95 percent confidence interval, 1.0 to 1.2; P = 0.02). The outcome in women under 45 years of age at the time of their first endometrial resections was slightly less favorable than the outcome in those 45 years old or older (relative risk of further surgery, 1.2; 95 percent confidence interval, 0.8 to 1.9). Uterine size and the type of endometrial preparation used were not related to the incidence of treatment failure.

Discussion

In our study, over 90 percent of women undergoing endometrial resection did not have hysterectomy, and 80 percent had no gynecologic surgery during the first five years after the resection. These results are consistent with those of some earlier studies,6-9,22 but other investigators have reported rates of reoperation within the year after surgery that are higher than our five-year rate.2,13-15 The outcome after laser ablation of the endometrium is equally variable.2,4,5,23 The most variable rates are those associated with the nonhysteroscopic techniques, which have cumulative rates of failure as high as 56 percent during the 12 months after surgery.2,24,25

One may speculate that techniques not performed under direct vision are more likely than other techniques to leave areas of endometrium untreated, but the variable results of hysteroscopic ablation must be explained in other ways. The surgeon's level of experience is one factor.23 In studies with high rates of success, the surgeons are usually more experienced. Because the depth of endometrial excision or destruction is known to be a predictor of outcome,26 it is likely that inexperienced surgeons, fearful of causing hemorrhage or uterine perforation, treat patients more superficially.

The duration of follow-up is another important determinant of outcome. We found that the rate of treatment failure reaches a plateau only after three years. Thus, outcomes appear better if women are followed for only one or two years. Life-table analysis provides a statistical model of the effect of time and also gives women a realistic indication of the likelihood that their surgery will succeed.

Two other factors play a major part in determining outcome. The results are better with the initial procedure and when the uterine cavity is normal. However, even among women who undergo more than one resection or require hysteroscopic myomectomy, over 70 percent do not have hysterectomy during the five years after surgery. Others have reported equally encouraging results in these situations.5,7,27,28

In our patients, recurrences of menorrhagia and dysmenorrhea or pelvic pain were the principal reasons for further surgery. The patients with menorrhagia and dysmenorrhea had good responses to such surgery, but those with cyclic pelvic pain associated with oligomenorrhea or amenorrhea were more difficult to treat. When a hematometra is present, it can be treated by cervical dilatation and drainage, possibly combined with a second endometrial ablation. Pelvic pain that develops after endometrial resection in the absence of a hematometra is difficult to explain or treat. Such pain could be due to fibroid degeneration, endometriosis, or adenomyosis, but adenomyosis is an uncommon histologic diagnosis at the time of resection8,9 or hysterectomy.28 Altered pelvic hemodynamics akin to those of the pelvic congestion syndrome may cause pain in some women. In these patients further endometrial resection is generally unhelpful. Laparoscopic surgery may be useful in women with endometriosis, but hysterectomy is often the only effective treatment. An approach combining hysteroscopy and laparoscopy has been suggested as the primary treatment when menorrhagia is associated with severe dysmenorrhea,29 but because dysmenorrhea generally lessens after endometrial resection alone,26,27 the use of an additional procedure is difficult to justify.

What is the role of endometrial resection in treating women with menorrhagia? The surgical nature of the treatment, coupled with its small but definite rate of complications, means that medical therapy must remain the first choice. The new intrauterine device containing levonorgestrel is another nonsurgical option.30 When medical treatment is contraindicated, poorly tolerated, unsuccessful, or resisted, endometrial resection is an effective mode of therapy, giving 9 in 10 women a chance of averting hysterectomy. Although there is debate about the effect of endometrial ablation on the overall rates of hysterectomy,31 it does offer women who are reluctant to undergo hysterectomy the dual advantages of relatively conservative surgery and freedom from prolonged medical therapy.

We are indebted to our many colleagues who referred patients for treatment and to those who assisted in the surgery, and to Dr. Richard Morris for help with the statistical analysis.

Source Information

From the Minimally Invasive Therapy Unit and the Endoscopy Training Centre, University Department of Obstetrics and Gynaecology, Royal Free Hospital, Pond St., Hampstead, London NW3 2QG, United Kingdom, where reprint requests should be addressed to Dr. Magos.

References

References

  1. 1

    Magos AL. Management of menorrhagia. BMJ 1990;300:1537-1538
    CrossRef | Web of Science | Medline

  2. 2

    Marsh M, Overton C, McPherson K. MISTLETOE update. London: Royal College of Obstetrics and Gynaecology, 1994 (pamphlet).

  3. 3

    Magos AL, Baumann R, Turnbull AC. Transcervical resection of endometrium in women with menorrhagia. BMJ 1989;298:1209-1212[Erratum, BMJ 1989;298:1428.]
    CrossRef | Web of Science | Medline

  4. 4

    Goldrath MH, Fuller TA, Segal S. Laser photovaporization of endometrium for the treatment of menorrhagia. Am J Obstet Gynecol 1981;140:14-19
    Web of Science | Medline

  5. 5

    Garry R, Erian J, Grochmal SA. A multi-centre collaborative study into the treatment of menorrhagia by Nd-Yag laser ablation of the endometrium. Br J Obstet Gynaecol 1991;98:357-362
    CrossRef | Medline

  6. 6

    Vancaillie TG. Electrocoagulation of the endometrium with the ball-end resectoscope. Obstet Gynecol 1989;74:425-427
    Web of Science | Medline

  7. 7

    Daniell JF, Kurtz BR, Ke RW. Hysteroscopic endometrial ablation using the rollerball electrode. Obstet Gynecol 1992;80:329-332
    Web of Science | Medline

  8. 8

    Maher PJ, Hill DJ. Transcervical endometrial resection for abnormal uterine bleeding -- report of 100 cases and review of the literature. Aust N Z J Obstet Gynaecol 1990;30:357-360
    CrossRef | Web of Science | Medline

  9. 9

    Magos AL, Baumann R, Lockwood GM, Turnbull AC. Experience with the first 250 endometrial resections for menorrhagia. Lancet 1991;337:1074-1078[Erratum, Lancet 1991;337:1362.]
    CrossRef | Web of Science | Medline

  10. 10

    Cooper MJW, Magos AL, Baumann R, Rees MCP. The effect of endometrial resection on menstrual blood loss. Gynaecol Endosc 1992;1:195-198

  11. 11

    Hill D, Maher P, Wood C, Lawrence A, Bowning B, Logatos N. Complications of operative hysteroscopy. Gynaecol Endosc 1992;1:185-189

  12. 12

    Magos AL, Baumann R, Cheung K, Turnbull AC. Intrauterine surgery under intravenous sedation as an outpatient alternative to hysterectomy. Lancet 1989;2:925-926
    CrossRef | Web of Science | Medline

  13. 13

    Gannon MJ, Holt EM, Fairbank J, et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ 1991;303:1362-1364
    CrossRef | Web of Science | Medline

  14. 14

    Dwyer N, Hutton J, Stirrat GM. Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. Br J Obstet Gynaecol 1993;100:237-243
    CrossRef | Medline

  15. 15

    Pinion SB, Parkin DE, Abramovich DR, et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ 1994;309:979-983
    CrossRef | Web of Science | Medline

  16. 16

    Lockwood M, Magos AL, Baumann R, Turnbull AC. Endometrial resection when hysterectomy is undesirable, dangerous or impossible. Br J Obstet Gynaecol 1990;97:656-658
    CrossRef | Medline

  17. 17

    Brooks PG, Serden SP, Davos I. Hormonal inhibition of the endometrium for resectoscopic endometrial ablation. Am J Obstet Gynecol 1991;164:1601-1608
    Web of Science | Medline

  18. 18

    Neuwirth RS. A new technique for and additional experience with hysteroscopic resection of submucous fibroids. Am J Obstet Gynecol 1978;131:91-94
    Web of Science | Medline

  19. 19

    Baumann R, Magos AL, Kay JDS, Turnbull AC. Absorption of glycine irrigating solution during transcervical resection of the endometrium. BMJ 1990;300:304-305
    CrossRef | Web of Science | Medline

  20. 20

    Survivorship tables. In: Armitage P, Berry G. Statistical methods inmedical research. 2nd ed. Oxford, England: Blackwell Scientific, 1987:408-13.

  21. 21

    Broadbent JAM, Molnar BG, Cooper MJW, Magos AL. Endoscopic management of uterine perforation occurring during endometrial resection. Br J Obstet Gynaecol 1992;99:1018-1018
    CrossRef | Medline

  22. 22

    Derman SG, Rehnstrom J, Neuwirth RS. The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas. Obstet Gynecol 1991;77:591-594
    Web of Science | Medline

  23. 23

    Davis JA. Hysteroscopic endometrial ablation with the neodymium-YAG laser. Br J Obstet Gynaecol 1989;96:928-932
    CrossRef | Medline

  24. 24

    Phipps JH, Lewis BV, Roberts T, et al. Treatment of functional menorrhagia by radiofrequency-induced thermal endometrial ablation. Lancet 1990;335:374-376
    CrossRef | Web of Science | Medline

  25. 25

    Singer A, Almanza R, Gutierrez A, Haber G, Bolduc LR, Neuwirth R. Preliminary clinical experience with a thermal balloon endometrial ablation method to treat menorrhagia. Obstet Gynecol 1994;83:732-734
    Web of Science | Medline

  26. 26

    Wortman M, Daggett A. Hysteroscopic endomyometrial resection: a new technique for the treatment of menorrhagia. Obstet Gynecol 1994;83:295-298
    Web of Science | Medline

  27. 27

    Indman PD. Hysteroscopic treatment of menorrhagia associated with uterine leiomyomas. Obstet Gynecol 1993;81:716-720
    Web of Science | Medline

  28. 28

    Gimpelson RJ, Kaigh J. Endometrial ablation repeat procedures: case studies. J Reprod Med 1992;37:629-635
    Web of Science | Medline

  29. 29

    Ewen SP, Sutton CJG. A combined approach for painful heavy periods: laparoscopic laser uterine nerve ablation and endometrial resection. Gynaecol Endosc 1994;3:167-168

  30. 30

    Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990;97:690-694
    CrossRef | Medline

  31. 31

    Coulter A. Trends in gynaecological surgery. Lancet 1994;344:1367-1367
    CrossRef | Web of Science | Medline

Citing Articles (77)

Citing Articles

  1. 1

    Azza A. Abd El Hameed. (2012) Endometrial thermal balloon ablation by a simple technique using Foley’s catheter with or without pre ablation endometrial curettage to treat cases with intractable menorrhagia. Middle East Fertility Society Journal
    CrossRef

  2. 2

    George Pados, Dimitrios Athanatos, Dimitrios Tsolakidis, Panagiotis Stamatopoulos, Basil Tarlatzis. (2011) Treatment options for dysfunctional uterine bleeding: evaluation of clinical results. Gynecological Surgery 8:4, 385-393
    CrossRef

  3. 3

    Christine A.R. Lok, Chris J. Poynter, John D. Tait. (2011) Life-Threatening Complications of Operative Hysteroscopy: A Case Report and Review of the Literature. Journal of Gynecologic Surgery 27:3, 179-183
    CrossRef

  4. 4

    David A. Iglesias, Shireen Madani Sims, John D. Davis. (2010) The effectiveness of endometrial ablation with the Hydro ThermAblator (HTA) for abnormal uterine bleeding. American Journal of Obstetrics and Gynecology 202:6, 622.e1-622.e6
    CrossRef

  5. 5

    Santiago Domingo, Antonio Pellicer. (2009) Overview of current trends in hysterectomy. Expert Review of Obstetrics & Gynecology 4:6, 673-685
    CrossRef

  6. 6

    Anette Berg, Leiv Sandvik, Anton Langebrekke, Olav Istre. (2009) A randomized trial comparing monopolar electrodes using glycine 1.5% with two different types of bipolar electrodes (TCRis, Versapoint) using saline, in hysteroscopic surgery. Fertility and Sterility 91:4, 1273-1278
    CrossRef

  7. 7

    Ian S Fraser, Sue Langham, Kerstin Uhl-Hochgraeber. (2009) Health-related quality of life and economic burden of abnormal uterine bleeding. Expert Review of Obstetrics & Gynecology 4:2, 179-189
    CrossRef

  8. 8

    Päivi H. Rovio, Riikka Helin, Pentti K. Heinonen. (2009) Long-term outcome of hysteroscopic endometrial resection with or without myomectomy in patients with menorrhagia. Archives of Gynecology and Obstetrics 279:2, 159-163
    CrossRef

  9. 9

    Mindyn K. Longinotti, Gavin F. Jacobson, Yun-Yi Hung, Lee A. Learman. (2008) Probability of Hysterectomy After Endometrial Ablation. Obstetrics & Gynecology 112:6, 1214-1220
    CrossRef

  10. 10

    Bent Brandt Hansen, Eva Dreisler, Søren Stampe Sørensen. (2008) Outcome of Repeated Hysteroscopic Resection of the Endometrium. Journal of Minimally Invasive Gynecology 15:6, 704-706
    CrossRef

  11. 11

    Herbert Gretz, William H. Bradley, Konstantin Zakashansky, Farr Nezhat, Jamal Rahaman, Linus Chuang, Deborah Loeb Bohren, Kenneth Kreiger, Elizabeth Rubin, Alan Sokolow. (2008) Patient clinical factors influencing use of hysterectomy in New York, 2001–2005. American Journal of Obstetrics and Gynecology 199:4, 349.e1-349.e5
    CrossRef

  12. 12

    Meredith K. Martin-Johnston, Olanma Y. Okoji, Alicia Armstrong. (2008) Therapeutic Amenorrhea in Patients at Risk for Thrombocytopenia. Obstetrical & Gynecological Survey 63:6, 395-402
    CrossRef

  13. 13

    C. Iavazzo, N. Salakos, K. Bakalianou, N. Vitoratos, G. Vorgias, A. Liapis. (2008) Thermal balloon endometrial ablation: a systematic review. Archives of Gynecology and Obstetrics 277:2, 99-108
    CrossRef

  14. 14

    Nikolaos P. Papadopoulos, Adam Magos. (2007) First-generation endometrial ablation: roller-ball vs loop vs laser. Best Practice & Research Clinical Obstetrics & Gynaecology 21:6, 915-929
    CrossRef

  15. 15

    Ioannis Stamatellos, John Bontis. (2007) Hysteroscopic myomectomy. European Clinics in Obstetrics and Gynaecology 3:1, 17-23
    CrossRef

  16. 16

    Ahmet Onoglu, Omur Taskin, Murat Inal, Salih Sadik, Mehmet Simsek, Munire Akar, Sinan Kursun, Inanc Mendilcioglu, Hakan Postaci, Cigdem Ispahi. (2007) Comparison of the long-term histopathologic and morphologic changes after endometrial rollerball ablation and resection: A prospective randomized trial. Journal of Minimally Invasive Gynecology 14:1, 39-42
    CrossRef

  17. 17

    Tamas Fulop, István Rákóczi, István Barna. (2007) NovaSure impedance controlled endometrial ablation: Long-term follow-up results. Journal of Minimally Invasive Gynecology 14:1, 85-90
    CrossRef

  18. 18

    Dacia D.C.A. Henriquez, Heleen van Dongen, Ron Wolterbeek, Frank Willem Jansen. (2007) Polypectomy in premenopausal women with abnormal uterine bleeding: Effectiveness of hysteroscopic removal. Journal of Minimally Invasive Gynecology 14:1, 59-63
    CrossRef

  19. 19

    Marlies Y Bongers. (2006) Endometrial ablation techniques: past, present and future. Expert Review of Obstetrics & Gynecology 1:1, 121-129
    CrossRef

  20. 20

    Franklin D Loffer. (2006) Endometrial ablation in patients with myomas. Current Opinion in Obstetrics and Gynecology 18:4, 391-393
    CrossRef

  21. 21

    G VILOS, B ABURAFEA. (2005) New developments in ambulatory hysteroscopic surgery. Best Practice & Research Clinical Obstetrics & Gynaecology 19:5, 727-742
    CrossRef

  22. 22

    Akas Jain, Nanette Santoro. (2005) Endocrine Mechanisms and Management for Abnormal Bleeding Due to Perimenopausal Changes. Clinical Obstetrics and Gynecology 48:2, 295-311
    CrossRef

  23. 23

    F LOFFER. (2005) Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concomitant endometrial ablation. Journal of Minimally Invasive Gynecology 12:3, 254-260
    CrossRef

  24. 24

    N BANU, I MANYONDA. (2005) Alternative medical and surgical options to hysterectomy. Best Practice & Research Clinical Obstetrics & Gynaecology 19:3, 431-449
    CrossRef

  25. 25

    Ilkka Rauramo, Iina Elo, Olav Istre. (2004) Long-Term Treatment of Menorrhagia With Levonorgestrel Intrauterine System Versus Endometrial Resection. Obstetrics & Gynecology 104:6, 1314-1321
    CrossRef

  26. 26

    Adolf Gallinat. (2004) NovaSure impedance controlled system for endometrial ablation: Three-year follow-up on 107 patients. American Journal of Obstetrics and Gynecology 191:5, 1585-1589
    CrossRef

  27. 27

    G VILOS. (2004) Hysteroscopic and nonhysteroscopic endometrial ablation. Obstetrics and Gynecology Clinics of North America 31:3, 687-704
    CrossRef

  28. 28

    Marlies Y. Bongers, Ben W.J. Mol, Hans A.M. Brölmann. (2004) Current treatment of dysfunctional uterine bleeding. Maturitas 47:3, 159-174
    CrossRef

  29. 29

    Panos Maouris, Rosalind Jamieson. (2004) Long-term success of endometrial resection: In everyday clinical practice, personal audit is more important than the knowledge of how the majority of surgeons perform. The Australian and New Zealand Journal of Obstetrics and Gynaecology 44:1, 65-67
    CrossRef

  30. 30

    T El-Toukhy, S Chandakas, T Grigoriadis, N Hill, J Erian. (2004) Outcome of the first 220 cases of endometrial balloon ablation using Cavaterm™<emph type="2">plus</emph>. Journal of Obstetrics & Gynaecology 24:6, 680-683
    CrossRef

  31. 31

    Jason Abbott, Jed Hawe, David Hunter, Ray Garry. (2003) A double-blind randomized trial comparing the Cavaterm™ and the NovaSure™ endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertility and Sterility 80:1, 203-208
    CrossRef

  32. 32

    Martin C Sowter. (2003) New surgical treatments for menorrhagia. The Lancet 361:9367, 1456-1458
    CrossRef

  33. 33

    Gaylene Pron, John Bennett, Andrew Common, Jane Wall, Murray Asch, Kenneth Sniderman. (2003) The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertility and Sterility 79:1, 120-127
    CrossRef

  34. 34

    Marius Braun, Alex Schoenfeld, Yaron Niv. (2002) Thermoablation of the Endometrium for Menorrhagia in a Patient Who Had a Small Bowel Transplantation. Journal of Clinical Gastroenterology 35:4, 360-362
    CrossRef

  35. 35

    Martin Lupton, T. Coltart. (2002) Transcervical resection of the endometrium and myometrium: a review of 111 patients after 6 years. Gynaecological Endoscopy 11:5, 235-238
    CrossRef

  36. 36

    Aubert Agostini, Ludovic Cravello, Raoul Desbriere, Anne Sophie Maisonneuve, Valerie Roger, Bernard Blanc. (2002) Hemorrhage risk during operative hysteroscopy. Acta Obstetricia et Gynecologica Scandinavica 81:9, 878-881
    CrossRef

  37. 37

    A KAUNITZ. (2002) Gynecologic problems of the perimenopause: evaluation and treatment. Obstetrics and Gynecology Clinics of North America 29:3, 455-473
    CrossRef

  38. 38

    Catharine Roberts, Nicholas Hill. (2002) Cervical and vaginal burn following hydro thermablation. Gynaecological Endoscopy 11:4, 213-214
    CrossRef

  39. 39

    Roselie A. Bright. (2002) The Conference on the Epidemiology of Medical Devices in Women. Epidemiology 13:Supplement, S1-S9
    CrossRef

  40. 40

    Theodore A. Panoskaltsis, Paul A. Bassett, Jonathan M. Frappell. (2002) Transcervical endometrial resection in 197 women. Hysterectomy rate and associated risk factors after a 5-8-year follow-up period. Gynaecological Endoscopy 11:2-3, 99-106
    CrossRef

  41. 41

    Ray Garry. (2002) Evidence and techniques in endometrial ablation: consensus. Gynaecological Endoscopy 11:1, 5-17
    CrossRef

  42. 42

    Fritz Wieser, Clemens Tempfer, Christine Kurz, Fritz Nagele. (2001) Hysteroscopy in 2001: a comprehensive review. Acta Obstetricia et Gynecologica Scandinavica 80:9, 773-783
    CrossRef

  43. 43

    Robert S. Neuwirth. (2001) Cost effective management of heavy uterine bleeding: ablative methods versus hysterectomy. Current Opinion in Obstetrics and Gynecology 13:4, 407-410
    CrossRef

  44. 44

    Olav Istre, Birgitta Trolle. (2001) Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertility and Sterility 76:2, 304-309
    CrossRef

  45. 45

    Kevin Jones, Jason Abbott, Jeremy Hawe, Christopher Sutton, Ray Garry. (2001) Endometrial laser intrauterine thermotherapy for the treatment of dysfunctional uterine bleeding: the first British experience. BJOG: An International Journal of Obstetrics and Gynaecology 108:7, 749-753
    CrossRef

  46. 46

    Adolf Gallinat, Ned Cosgriff. (2001) Endometrial ablation by electroballoon coagulation: long-term results. Gynaecological Endoscopy 10:1, 37-43
    CrossRef

  47. 47

    Christian Kremer, Sean Duffy. (2000) Endometrial ablation: the next generation. BJOG: An International Journal of Obstetrics and Gynaecology 107:12, 1443-1452
    CrossRef

  48. 48

    Britt Friberg, Mats Ahlgren. (2000) Thermal balloon endometrial destruction: the outcome of treatment of 117 women followed up for a maximum period of 4 years. Gynaecological Endoscopy 9:6, 389-395
    CrossRef

  49. 49

    DOROTHY N. KAMMERER-DOAK, R. G. ROGERS. (2000) Endometrial Ablation: Electrocautery and Laser Techniques. Clinical Obstetrics and Gynecology 43:3, 561-574
    CrossRef

  50. 50

    Mark Roberts, Stuart M. Walton. (2000) The effect of paracervical adrenaline on blood loss in patients undergoing transcervical resection of the endometrium. Gynaecological Endoscopy 9:3, 153-156
    CrossRef

  51. 51

    Philip G. Brooks. (2000) Treatment of the patient without intracavitary pathologyComparison of traditional hysteroscopic techniques for endometrial ablation. Obstetrics and Gynecology Clinics of North America 27:2, 339-345
    CrossRef

  52. 52

    Dennis A. Hidlebaugh. (2000) Cost and quality-of-life issues associated with different surgical therapies for the treatment of abnormal uterine bleeding. Obstetrics and Gynecology Clinics of North America 27:2, 451-465
    CrossRef

  53. 53

    David E. Parkin. (2000) Endometrial resection and ablation: past, present and future. Gynaecological Endoscopy 9:1, 1-7
    CrossRef

  54. 54

    Jeremy A. Hawe, A. Graham Phillips, Patrick F. W. Chien, John Erian, Ray Garry. (1999) Cavaterm thermal balloon ablation for the treatment of menorrhagia. BJOG: An International Journal of Obstetrics and Gynaecology 106:11, 1143-1148
    CrossRef

  55. 55

    Seth A. Stabinsky, Mark Einstein, James L. Breen. (1999) Modern Treatments of Menorrhagia Attributable to Dysfunctional Uterine Bleeding. Obstetrical & Gynecological Survey 54:Supplement, 251-262
    CrossRef

  56. 56

    Roger Hart, Bela G. Molnar, Adam Magos. (1999) Long term follow up of hysteroscopic myomectomy assessed by survival analysis. BJOG: An International Journal of Obstetrics and Gynaecology 106:7, 700-705
    CrossRef

  57. 57

    (1999) A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. BJOG: An International Journal of Obstetrics and Gynaecology 106:4, 360-366
    CrossRef

  58. 58

    J COOPER, R BRADY. (1999) HYSTEROSCOPY IN THE MANAGEMENT OF ABNORMAL UTERINE BLEEDING. Obstetrics and Gynecology Clinics of North America 26:1, 217-236
    CrossRef

  59. 59

    Saurabh V. Gandhi, Kenneth B. C. Fear, David W. Sturdee. (1999) Endometrial resection: factors affecting long-term success. Gynaecological Endoscopy 8:1, 41-50
    CrossRef

  60. 60

    Seth A. Stabinsky, Mark Einstein, James L. Breen. (1999) Modern Treatments of Menorrhagia Attributable to Dysfunctional Uterine Bleeding. Obstetrical & Gynecological Survey 54:1, 61-72
    CrossRef

  61. 61

    M. P. Milligan, G. A. Etokowo. (1999) Microwave endometrial ablation for menorrhagia. Journal of Obstetrics & Gynaecology 19:5, 496-499
    CrossRef

  62. 62

    MARLIES Y. BONGERS, BEN W.J. MOL, HANS A.M. BRÖLMANN. (1999) Comparison of 8 versus 16 Minutes Heating in the Treatment of Menorrhagia with Hot Fluid Balloon Ablation. Journal of Gynecologic Surgery 15:3, 143-148
    CrossRef

  63. 63

    Arjav A Shah, Seth A Stabinsky, Thomas Klusak, Kent R Bradley, John F Steege, David A Grainger. (1998) Measurement of serosal temperatures and depth of thermal injury generated by thermal balloon endometrial ablation in ex vivo and in vivo models. Fertility and Sterility 70:4, 692-697
    CrossRef

  64. 64

    Graham Phillips, Patrick F. W. Chien, Ray Carry. (1998) Risk of hysterectomy after 1000 consecutive endometrial laser ablations. BJOG: An International Journal of Obstetrics and Gynaecology 105:8, 897-903
    CrossRef

  65. 65

    Roger Hart, Adam Magos. (1998) Prognostic factors for success of endometrial ablation and resection. The Lancet 352:9121, 68-69
    CrossRef

  66. 66

    Fritz Nagele, Tarina Rubinger, Adam Magos. (1998) Why Do Women Choose Endometrial Ablation Rather Than Hysterectomy?. Fertility and Sterility 69:6, 1063-1066
    CrossRef

  67. 67

    Nazar N. Amso, Seth A. Stabinsky, Peter McFaul, Bernard Blanc, Laura Pendley, Robert Neuwirth. (1998) Uterine thermal balloon therapy for the treatment of menorrhagia: the first 300 patients from a multi-centre study. BJOG: An International Journal of Obstetrics and Gynaecology 105:5, 517-523
    CrossRef

  68. 68

    W. PARKAR. (1998) Adenomyosis following endometrial resection-a retrospective study. Journal of Obstetrics & Gynaecology 18:6, 564-565
    CrossRef

  69. 69

    Ray Garry. (1997) Endometrial ablation and resection: validation of a new surgical concept. BJOG: An International Journal of Obstetrics and Gynaecology 104:12, 1329-1331
    CrossRef

  70. 70

    RAYMOND W. KE. (1997) Endometrial Ablation: An Alternative to Hysterectomy. Clinical Obstetrics and Gynecology 40:4, 914-927
    CrossRef

  71. 71

    James B. Unger, G.Rodney Meeks. (1997) Reply. American Journal of Obstetrics and Gynecology 177:3, 717
    CrossRef

  72. 72

    Hugh O'Connor, Adam Magos. (1997) Life tables without confidence intervals may mislead. American Journal of Obstetrics and Gynecology 177:3, 716-717
    CrossRef

  73. 73

    Jacques Donnez, George Vilos, Michael J. Gannon, Søren Stampe-Sorensen, Ingemar Klinte, Robert M. Miller. (1997) Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study. Fertility and Sterility 68:1, 29-36
    CrossRef

  74. 74

    Charles L. Moir, Henry Mandin, Rollin Brant. (1997) Sorbitol 2.5% mannitol 0.54% irrigation solution for hysteroscopic endometrial ablation surgery. Canadian Journal of Anaesthesia 44:5, 473-478
    CrossRef

  75. 75

    Béla G. Molnár, Ralf Baumann, Adam L Magos. (1997) Does endometrial resection help dysmenorrhea?. Acta Obstetricia et Gynecologica Scandinavica 76:3, 261-265
    CrossRef

  76. 76

    Hugh O'Connor, J A Mark Broadbent, Adam L Magos, K McPherson. (1997) Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. The Lancet 349:9056, 897-901
    CrossRef

  77. 77

    Carlson, Karen J., Schiff, Isaac, . (1996) Alternatives to Hysterectomy for Menorrhagia. New England Journal of Medicine 335:3, 198-199
    Full Text

Trends: Most Viewed (Last Week)

More Trends